ZO-1 expression and phosphorylation in diabetic nephropathy

Area of Science:

• Nephrology
• Cell Biology
• Diabetology

Background:

• Diabetic nephropathy is characterized by loss of capillary wall permselectivity.
• The role of junctional proteins like Zonula Occludens-1 (ZO-1) in this process is not fully understood.
• ZO-1 is crucial for tight junction assembly and function, and is present in podocytes.

Purpose of the Study:

• To investigate the impact of diabetes and high glucose on ZO-1 expression and localization.
• To explore the potential role of ZO-1 alterations in diabetic kidney disease pathogenesis.

Main Methods:

• Utilized animal models of type 1 and type 2 diabetes.
• Employed immunohistochemistry, Western blotting, and immunogold electron microscopy.
• Studied rat glomerular epithelial cells exposed to high glucose concentrations.

Main Results:

• Diabetic animals showed decreased glomerular ZO-1 expression.
• ZO-1 redistributed from the podocyte membrane to the cytoplasm in diabetic conditions.
• High glucose exposure decreased ZO-1 staining intensity and caused redistribution, effects attenuated by angiotensin II type 1 receptor blockade.
• ZO-1 protein expression and phosphorylation were reduced by high glucose.

Conclusions:

• Alterations in ZO-1 content and localization are implicated in the development of proteinuria in diabetic nephropathy.
• Targeting the angiotensin II type 1 receptor may mitigate high glucose-induced ZO-1 changes.